[Possibilities of using the noninvasive methods of investigating the morphofunctional changes in the liver in patients with non alcoholic steatohepatitis and type 2 diabetes mellitus].

Unlabelled: PURPOSE OF A STUDY: To estimate the possibility of applying the complex of the noninvasive methods of investigating the state of the liver for finalizing of the ways of the differentiated pathogenetic therapy.

Materials And Method: Over the 2008 to 2013 period was carried out the open comparative study, in which were included 75 patients with non alcoholic steatohepatitis (NASH) and type 2 diabetes mellitus (SD). The Menghini Method of Liver biopsy was carried out for histological study.

[Lanzoptol efficacy at gastroesophageal reflux disease: results of multicenter study leader].

Results of multicenter study "Efficacy of Lansoptol (lansoprazole, KRKA) and its influence on the Dynamics of GERD symptoms" (LIEDER) are presented. The impact of 56-days treatment with lansoprazole 30 mg once daily on symptoms relief, a quality of life of 121 patients with gastroesophageal reflux disease (GERD) and healing of esophageal lesions of 30 patients with reflux esophagitis were investigated. Rapid acid inhibition effect of first dose of lansoptol was shown by 48-hr pH-monitoring.

[Use of three-dimensional ultrasound visualization in differential diagnosis of pancreatic head diseases].

Retrospective analysis of 3D-reconstruction of ultrasound images is discussed with reference to the diagnosis of pancreatic disorders, such as pseudotumorous pancreatitis and pancreatic head neoplasm, based on the data extracted from case records collected in the Central Clinical Hospital No 1, OJSC RZhD, for the period of 2004-2008. In addition, comparative analysis is presented of different beam diagnostics methods for the examination of hepatobiliary system (classical ultrasound, 3D-reconstruction of ultrasound images, CT, endoscopic techniques, e.g.

[Blood levels of HbsAg in patients with different variants of chronic HBV-infection].

Aim: To estimate HbsAg in patients with different variants of chronic HBV infection.

Material And Methods: Assay of HbsAg (IU/ml) in blood serum was made in 156 patients with chronic HBV infection (70 males and 86 females, age 19 to 78 years) using the test-system HbsAg Architect Lot 59665LF00 (Abbott) on the automatic analyzer Architect with construction of 4-parameter logistic curve.

Results: There are significant differences in the levels of HbsAg depending on the course of chronic HBV-infection: inactive carriers of HBV (12,884.